PolyPeptide Group AG
A global CDMO specializing in peptide and oligonucleotide APIs for pharma and biotech partners.
PPGN | SW
Overview
Corporate Details
- ISIN(s):
- CH1110760852
- LEI:
- 5067007JCKTPOX4G9758
- Country:
- Switzerland
- Address:
- Neuhofstrasse 24, 6340 Baar
- Website:
- https://www.polypeptide.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
PolyPeptide Group AG is a global Contract Development & Manufacturing Organization (CDMO) specializing in peptide- and oligonucleotide-based active pharmaceutical ingredients (APIs). The company provides comprehensive services to pharmaceutical and biotech partners, supporting the development and manufacturing of both proprietary and generic products. PolyPeptide assists clients throughout the product lifecycle, from initial development to regulatory approval and commercial launch. A key focus is on innovation in large-scale production and sustainable manufacturing processes, such as green peptide chemistry, to enhance process performance while minimizing environmental impact.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-09-22 07:00 |
Regulatory News Service
PolyPeptide Group achieves significant milestone in Malmo expansion project
|
English | 10.6 KB | ||
| 2025-09-22 02:00 |
Regulatory News Service
PolyPeptide Group achieves significant milestone in Malmö expansion project
|
English | 8.5 KB | ||
| 2025-08-12 06:55 |
Earnings Release
PolyPeptide delivers +24% growth in H1 2025, successful ramp-up at its Belgian …
|
English | 31.7 KB | ||
| 2025-08-12 02:00 |
Earnings Release
PolyPeptide delivers +24% growth in H1 2025, successful ramp-up at its Belgian …
|
English | 28.4 KB | ||
| 2025-08-12 02:00 |
Earnings Release
PolyPeptide wächst im ersten Halbjahr 2025 um 24%, mit einer erfolgreichen Anla…
|
German | 32.6 KB | ||
| 2025-05-23 07:00 |
Capital/Financing Update
PolyPeptide announces expansion of existing credit facilities
|
English | 7.8 KB | ||
| 2025-05-23 02:00 |
Capital/Financing Update
PolyPeptide announces expansion of existing credit facilities
|
English | 6.0 KB | ||
| 2025-05-23 02:00 |
Capital/Financing Update
PolyPeptide gibt Ausweitung des bestehenden Kreditrahmens bekannt
|
German | 7.0 KB | ||
| 2025-04-09 18:34 |
Post-Annual General Meeting Information
PolyPeptide announces results of the annual General Meeting 2025
|
English | 9.3 KB | ||
| 2025-03-19 07:00 |
Pre-Annual General Meeting Information
PolyPeptide publishes invitation to the annual General Meeting 2025
|
English | 8.8 KB | ||
| 2025-03-18 07:00 |
Pre-Annual General Meeting Information
PolyPeptide publishes invitation to the annual General Meeting 2025
|
English | 8.8 KB | ||
| 2025-03-18 01:00 |
Pre-Annual General Meeting Information
PolyPeptide publishes invitation to the annual General Meeting 2025
|
English | 7.1 KB | ||
| 2025-03-18 01:00 |
Pre-Annual General Meeting Information
PolyPeptide publiziert Einladung zur ordentlichen Generalversammlung 2025
|
German | 8.0 KB | ||
| 2025-03-12 06:55 |
Earnings Release
PolyPeptide with substantial improvements in profitability and cash flow, posit…
|
English | 32.1 KB | ||
| 2025-03-11 06:55 |
Earnings Release
PolyPeptide with substantial improvements in profitability and cash flow, posit…
|
English | 32.1 KB |
Automate Your Workflow. Get a real-time feed of all PolyPeptide Group AG filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for PolyPeptide Group AG
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for PolyPeptide Group AG via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-04-09 | N/A | Non-Executive member | Buy | None | 75,000.00 CHF |
| 2025-04-09 | N/A | Non-Executive member | Buy | None | 72,000.00 CHF |
| 2025-04-09 | N/A | Non-Executive member | Buy | None | 50,000.00 CHF |
| 2024-04-11 | N/A | Non-Executive member | Buy | None | 75,000.00 CHF |
| 2024-04-11 | N/A | Non-Executive member | Buy | None | 72,000.00 CHF |
| 2024-04-11 | N/A | Non-Executive member | Buy | None | 50,000.00 CHF |
| 2024-04-11 | N/A | Non-Executive member | Buy | None | 35,000.00 CHF |
| 2023-11-10 | N/A | Executive member | Buy | None | 51,250.00 CHF |
| 2023-10-11 | N/A | Executive member | Buy | None | 2,876,348.62 CHF |
| 2023-10-10 | N/A | Executive member | Buy | None | 371,202.96 CHF |
